Close
The ALS RAP

The ALS RAP

Reading Time: 5 minutes Yesterday, we were delighted to unveil a new research collaboration that we believe will greatly improve the quality and pace of MND research – not only in understanding the cellular processes that cause motor neurons to degenerate, but also in helping with drug discovery and development. The Amyotrophic Lateral Sclerosis Reproducible Antibody Platform (ALS RAP) isn’t…

Understanding disease variability – the 2017 IPG prize winner

Understanding disease variability – the 2017 IPG prize winner

Reading Time: 3 minutes Warmest congratulation to Dr Marka van Blitterswijk of the Mayo Clinic in Jacksonville, Florida, winner of this year’s Paulo Gontijo Prize in Medicine. The Award is presented to an outstanding young investigator working on ALS/MND, with judging based on the significance of a recent scientific paper published by each applicant, plus an evaluation of the…

Lithium revisited: Is there a baby in the bathwater?

Reading Time: 3 minutes At last year’s Airlie House workshop to develop new ALS/MND Clinical Trial Guidelines the focus was, of course, on MND, but there was also important input and learning from outside the field. One of the most fascinating presentations was from an oncologist who was explaining how detailed genetic analysis of tumours was leading to an understanding…

IPG Prize recognises young research talent

Reading Time: 2 minutes I firmly believe that the quality of research is only as good as the researcher doing it, which is why the MND Association places a lot of emphasis on providing opportunities to attract, train and retain the brightest and best investigators in the UK and Ireland to develop their careers in MND research. These range…